Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tap

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcomaChand Khanna, Timothy M Fan, Richard Gorlick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in SarcomaEvan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, et al.
ESMO Open|September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working GroupC Giani, R A Denu, S Ljevar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated LiposarcomaCaroline E Gleason, Mark A Dickson, Mary E Klein Dooley, et al.
The New England Journal of Medicine|July 30, 2015
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell TumorWilliam D Tap, Zev A Wainberg, Stephen P Anthony, et al.
Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcomaChand Khanna, Timothy M Fan, Richard Gorlick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in SarcomaEvan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, et al.
ESMO Open|September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working GroupC Giani, R A Denu, S Ljevar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated LiposarcomaCaroline E Gleason, Mark A Dickson, Mary E Klein Dooley, et al.
The New England Journal of Medicine|July 30, 2015
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell TumorWilliam D Tap, Zev A Wainberg, Stephen P Anthony, et al.
Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkG D Demetri, C R Antonescu, B Bjerkehagen, et al.
Pageof 24